All subordinate units of the group commend the annual advanced
Release time:
2022-02-08
2021 , and arrange the work for the new year. # July 19
, at the2021 work summary commendation meeting held by Yunnan Jianfeng Cement Company, Liu Shenghua, general manager of Yunnan Jianfeng, made a work report on behalf of Yunnan Jianfeng management team, summarizing the production and operation of 2021 . 2021 Yunnan Peak overcame the impact of the epidemic and new regional capacity, the general price increase of raw combustion materials, the difficulties of low-cost market competition in the release of capacity by peers in the region, and the difficulties of peak production due to power-limiting policies and high-energy-consuming industries for the purpose of reducing carbon emissions. In the difficult market environment, to ensure the peak in the regional volume, price, the overall lead, in the absence of key project support to maintain the regional cement sales of the highest enterprises, effectively maintain and improve the market share of the peak brand. Liu Shenghua objectively analyzed the problems and deficiencies in the previous work, and put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2022 in combination with the actual work in 2021 . The meeting commended the advanced collectives, advanced teams, advanced departments and advanced individuals who have made remarkable achievements in the work of 2021
. Representatives of advanced departments and advanced individuals made typical speeches. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, in the face of heavy production and operation tasks, Strive to catch up and surpass head-on this year and set new highs.1 July 20
, daye peak cement company held a summary commendation meeting. Zhang Fengliang, deputy general manager of the group company and general manager of daye peak, made a work report for2021 . 2021 , facing the adverse effects of "carbon peak, carbon neutral " , energy consumption double control policy, price rise of raw fuel materials, daye peak maintained and carried forward the work style of "fight, rob, real " , overcome the external environment changes such as market ups and downs, coal price rise sharply, and continued to promote technological transformation, continuously solve the bottleneck restricting production, technical and economic indicators continue to improve, production capacity, sales can be effectively played. Zhang Fengliang analyzed the challenges faced by the cement industry in the future and the shortcomings in the internal management of the enterprise. He asked all managers to evaluate their employees well, reward and praise their good behavior through the red list in a timely manner, guide and encourage employees with poor performance, encourage them to learn from the advanced and create a good working atmosphere. All employees should cherish their current jobs and encourage them to continuously improve their abilities, strengthen responsibility, become the backbone of the enterprise and future project development, and grow together with the peak; all employees should further improve their execution, based on their own work, and do a solid job in various tasks. The meeting also issued honorary certificates to representatives of advanced individuals and advanced collectives. Yin Weixiong, representative of the electricians class of the manufacturing department, and Cao Jiangfeng, representative of advanced individuals, spoke on behalf of advanced collectives and advanced individuals respectively. Wang Yuhua, manager of the comprehensive management department, explained to the conference on personnel-related systems. All the delegates at the conference reviewed and voted on salary management, attendance management system, labor contract management system and monthly evaluation management system. At the annual summary commendation meeting of Huang ping peak cement company 2021
held on the afternoon of1
July20 , Hu hongwei, general manager of Huang ping peak cement company, made an annual work report of 2021 to the conference, this paper makes a comprehensive summary and review of the work in 2021 from nine aspects, including the completion of production and operation, quality management, marketing management, procurement management, safety and environmental protection, human resources, external coordination, party and industrial group work, and technological transformation work. It also makes a strategic layout and sets work objectives for the work in 2022 . Lu Hongzheng, deputy general manager of Huang Ping Jianfeng, read out the list of advanced collectives and individuals within the group company and the enterprise in 2021
on behalf of Huang Ping Jianfeng. In a warm atmosphere, the advanced representatives within the enterprise came to the stage wearing red ribbons to receive the award. In his speech, the advanced representative said that he would make persistent efforts in the new year, carry forward the fine tradition of passing on and leading the peak, and lead the peak people to build Huang Ping into a benchmark enterprise in Qiandongnan Prefecture.1 May 27
, the summary commendation meeting held by Jianfeng Pharmaceutical Company presented awards to advanced collectives and outstanding individuals, summarized the work of the previous year, deployed the work of the new year, and signed the target responsibility system for the next year with the heads of subordinate enterprises. In the work report, Huang Jinlong, deputy general manager ofgroup company and general manager of pharmaceutical company, summarized the achievements made by pharmaceutical company in adjusting internal management structure, organization setting, sales area optimization, integrating financial accounting system, optimizing process, strengthening quality control, project construction and information construction in the previous year. In the face of frequent national pharmaceutical industry policies, drug collection speed expansion, continuous promotion of the status quo, pharmaceutical companies next year will pay more attention to medical insurance, basic drugs, key monitoring and other catalogs, focus on doing a good job in the market access of drugs around the work, innovative marketing system, tap product advantages, enhance market expansion capacity.
Chairman of the Group Company and Chairman of the Pharmaceutical Company Jiang Xiaomeng and the management team of the Pharmaceutical Company presented awards to advanced collectives and outstanding individuals. Wu Weisheng, He Songqin, Wang Liqin, and Chen Yumiao respectively represented the group's outstanding management workers, Advanced collectives, outstanding scientific and technological workers and outstanding members delivered acceptance speeches.
In the concluding speech of the meeting, Jiang Xiaomeng commented on the work of the pharmaceutical company in the previous year and put forward guidance on the work direction of the peak pharmaceutical sector 2022
. He emphasized that the group company has always placed high hopes on the future development of pharmaceutical companies. Pharmaceutical companies must break through their inherent thinking, seize profit points, and improve weak points. Find the right track, develop ophthalmic drugs, strengthen the development of improved drugs, power medical intermediates. Compact responsibility, seriously reflect on the review, find ways to improve the speed of new drug development, clear idle capacity. The combination of sales guarantee and increase, open the sales market, broaden the sales channels, guarantee the quantity of basic products, seize the market opportunity to create benefits, and strive to greatly increase the sales volume. Improve quality and reduce costs in production, starting from the procurement of raw materials, the quality of production workers and the improvement of production processes to reduce production costs. Work together in many ways to get out of the bottleneck and reach the annual goal for the new year.1 January 28
, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made the annual work report of2021 . She reviewed the work of 2021 and put forward requirements for the work of 2022 around the theme of "accelerating technological transformation, increasing efficiency and reducing costs, breaking through self, expanding the market, enabling each other to create benefits " , call on all employees of the cable company to continue to carry forward the work style of "unity, pragmatism and attentiveness " , cherish the achievements of 2021 , strengthen the goal and direction, make strong logarithmic communication cables, make professional subway communication cables, and strive to become the leading position in the subdivided industry. The meeting also commended the advanced collectives and individuals in the year of 2021 . On the afternoon of
, employees summed up the past and shared the future at the summary and commendation meeting of Jianfeng Health Technology Company. The peak health management team presented awards to advanced collectives, outstanding employees and 11 outstanding salesmen. Yin Zhiwu, general manager of Jianfeng Health, said that 2022 , the Jianfeng Health team will work together to firmly believe and unite sincerely, with the business idea of developing healthy products as the main product, supplemented by plant extracts and Chinese herbal pieces, strive to create fist products, maintain the existing entrusted processing business, enhance the business increment of investment promotion, group purchase, terminal and 11 , and make use of agent sales channels; and explore new retail, conference marketing, live broadcast and other new modes; According to the needs of enterprise development, develop products with market competitiveness, organize production and operation in strict accordance with the requirements of GMP and food regulations, strengthen the level of quality supervision, strictly grasp the work of safety and environmental protection, and strive to exceed the targets issued by the group in 2022 . (Qi Jianmei
Wang YuhuaPan Yi Chen Shengmu Huang Yuan Zhou Huijuan)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31